X-60
DEAD

Serial Number

88431149

Owner

Essenlix Corporation

Attorney

Julian D. Gonzalez

Filing Date

May 15, 2019

Add to watchlist:

No watchlists yet
View on USPTO

X-60 Trademark

Serial Number: 88431149

X-60 is a trademark filed by Essenlix Corporation on May 15, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Essenlix Corporation (148 trademarks)

7 Foulet Dr
Princeton, CA 08540

Entity Type: 03

Trademark Details

Filing Date

May 15, 2019

Registration Date

Not Registered

Published for Opposition

February 11, 2020

Goods & Services

Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases

Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, or diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use

Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing health and wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing in the nature of the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases, diagnostic testing, namely, medical testing for diagnostic purposes, and wellness services, namely, providing wellness information in the fields of health and wellness, all of the foregoing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes

Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point- of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 7, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 7, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2022 EXRA
SOU EXTENSION 4 GRANTED
Mar 31, 2022 EX4G
SOU EXTENSION 4 FILED
Mar 31, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 31, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 6, 2021 EXRA
SOU EXTENSION 3 GRANTED
Oct 4, 2021 EX3G
SOU EXTENSION 3 FILED
Oct 4, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 4, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2021 EXRA
SOU EXTENSION 2 GRANTED
Mar 31, 2021 EX2G
SOU EXTENSION 2 FILED
Mar 31, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 31, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 1, 2020 EXRA
SOU EXTENSION 1 GRANTED
Sep 29, 2020 EX1G
SOU EXTENSION 1 FILED
Sep 29, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 29, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 31, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 31, 2019 CRFA
ASSIGNED TO LIE
Dec 31, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 11, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 31, 2019 NWOS
NEW APPLICATION ENTERED
May 18, 2019 NWAP